Literature DB >> 3726122

Uterine cervical cancer: assessment with high-field MR imaging.

K Togashi, K Nishimura, K Itoh, I Fujisawa, R Asato, Y Nakano, H Itoh, K Torizuka, H Ozasa, T Mori.   

Abstract

Nineteen patients with histologically proved cervical carcinoma were evaluated with magnetic resonance (MR) imaging. Clinical, MR, and surgical findings were compared to determine accuracy and clinical usefulness of MR in demonstrating mass and extent of disease. MR imaging enabled clear differentiation of corpus uteri, cervix, vagina, uterine ligaments, and tumor. Tumor was demonstrated as a high-intensity mass deforming the low-intensity cervix; the low background intensity of normal structures provided high contrast to the mass. MR imaging accurately demonstrated the tumor in all ten patients with locally advanced cervical carcinoma and showed a normal cervix in nine patients with early cancer. On sagittal images, the shape of corpus uteri, cervix, and vagina, and their relationship to the mass were clearly assessed, with their long axes usually in a single plane. On axial images, assessment of parametrial tumor extension was facilitated by clear definition of the low-intensity cervix and uterine ligaments. Although more study is needed to determine the accuracy of MR in staging, MR is a promising method in evaluating cervical carcinoma.

Entities:  

Mesh:

Year:  1986        PMID: 3726122     DOI: 10.1148/radiology.160.2.3726122

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Magnetic resonance imaging in oncology.

Authors:  J E Husband; R Guy
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

2.  Volume Measurement by Diffusion-Weighted Imaging in Cervical Cancer.

Authors:  Shinya Fujii; Naoki Iwata; Chie Inoue; Naoko Mukuda; Takeru Fukunaga; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

3.  [MR in gynecology and obstetrics].

Authors:  A Breit; H Becker; K Pfändner
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

4.  Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth.

Authors:  Ming Yang; Tao Yu; Ying-Ying Wang; Samuel K Lai; Qi Zeng; Bolong Miao; Benjamin C Tang; Brian W Simons; Laura M Ensign; Guanshu Liu; Kannie W Y Chan; Chih-Yin Juang; Olcay Mert; Joseph Wood; Jie Fu; Michael T McMahon; T-C Wu; Chien-Fu Hung; Justin Hanes
Journal:  Adv Healthc Mater       Date:  2013-12-16       Impact factor: 9.933

5.  Comparison of T2-weighted and contrast-enhanced T1-weighted MR imaging at 1.5 T for assessing the local extent of cervical carcinoma.

Authors:  Ayano Akita; Hiroshi Shinmoto; Shigenori Hayashi; Hirotaka Akita; Takuma Fujii; Shuji Mikami; Akihiro Tanimoto; Sachio Kuribayashi
Journal:  Eur Radiol       Date:  2011-04-09       Impact factor: 5.315

Review 6.  Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis.

Authors:  Maarten G Thomeer; Cees Gerestein; Sandra Spronk; Helena C van Doorn; Els van der Ham; Myriam G Hunink
Journal:  Eur Radiol       Date:  2013-03-01       Impact factor: 5.315

Review 7.  Staging of carcinoma of the uterine cervix and endometrium.

Authors:  Takashi Koyama; Ken Tamai; Kaori Togashi
Journal:  Eur Radiol       Date:  2007-01-12       Impact factor: 7.034

8.  Early Cervical Cancer: Predictive Relevance of Preoperative 3-Tesla Multiparametric Magnetic Resonance Imaging.

Authors:  Hyun Jin Roh; Kyung Bin Kim; Jong Hwa Lee; Hwa Jung Kim; Yong-Soon Kwon; Sang Hun Lee
Journal:  Int J Surg Oncol       Date:  2018-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.